Advertisement

Ads Placeholder
Loading...

Lucid Diagnostics Inc.

LUCD•NASDAQ
Healthcare
Medical - Devices
$1.14
$-0.01(-0.87%)
U.S. Market opens in 20h 5m

Lucid Diagnostics Inc. (LUCD) Stock Overview

Explore Lucid Diagnostics Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap116.6M
P/E Ratio-2.00
EPS (TTM)$-0.69
ROE-5.91%
Fundamental Analysis

AI Price Forecasts

1 Month$1.55
3 Months$1.39
1 Year Target$1.14

LUCD Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Lucid Diagnostics Inc. (LUCD) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 32.40, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.14.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -2.00 and a market capitalization of 116.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.87%
5-Day Change
-0.87%
1-Month Change
-21.38%
3-Month Change
1.79%
6-Month Change
9.62%
Year-to-Date (YTD) Change
1.79%
1-Year Change
-24.00%
3-Year Change
-14.29%
5-Year Change
-90.31%
All-Time (Max) Change
-90.31%

Contact Information

https://www.luciddx.com
212 949 4319
One Grand Central Place, New York City, NY, 10165

Company Facts

720 Employees
IPO DateOct 14, 2021
CountryUS
Actively Trading

Frequently Asked Questions